Eiki Kikuchi

3.5k total citations
65 papers, 2.4k citations indexed

About

Eiki Kikuchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Eiki Kikuchi has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Eiki Kikuchi's work include Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Tracheal and airway disorders (10 papers). Eiki Kikuchi is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Tracheal and airway disorders (10 papers). Eiki Kikuchi collaborates with scholars based in Japan, United States and Spain. Eiki Kikuchi's co-authors include Masaharu Nishimura, Koichi Yamazaki, Satoshi Oizumi, Naofumi Shinagawa, Junko Kikuchi, Hajime Asahina, Hirotoshi Dosaka‐Akita, Yuya Onodera, Ichiro Kinoshita and Noriaki Kurimoto and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Eiki Kikuchi

59 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiki Kikuchi Japan 25 1.4k 756 675 267 232 65 2.4k
Giulia Maria Stella Italy 23 784 0.6× 564 0.7× 540 0.8× 317 1.2× 187 0.8× 111 2.1k
Stefania Croci Italy 27 835 0.6× 733 1.0× 518 0.8× 542 2.0× 216 0.9× 109 2.4k
Roland E. Knoblauch United States 22 1.3k 0.9× 738 1.0× 1.1k 1.7× 189 0.7× 225 1.0× 85 2.2k
Kenzo Soejima Japan 34 1.5k 1.1× 1.3k 1.7× 1.1k 1.6× 368 1.4× 523 2.3× 129 3.0k
Chadrick E. Denlinger United States 23 638 0.5× 677 0.9× 447 0.7× 162 0.6× 210 0.9× 58 1.6k
Jung Wook Park United States 19 727 0.5× 663 0.9× 652 1.0× 109 0.4× 317 1.4× 28 1.5k
Daniel L. Suzman United States 19 812 0.6× 352 0.5× 1.3k 1.9× 318 1.2× 250 1.1× 59 2.0k
Fumihiro Oshita Japan 26 1.1k 0.8× 579 0.8× 1.1k 1.6× 99 0.4× 181 0.8× 124 2.0k
Michael Kraut United States 24 1.0k 0.7× 489 0.6× 832 1.2× 179 0.7× 110 0.5× 58 1.9k
Giovanni Schinzari Italy 27 761 0.5× 501 0.7× 1.5k 2.2× 325 1.2× 258 1.1× 116 2.2k

Countries citing papers authored by Eiki Kikuchi

Since Specialization
Citations

This map shows the geographic impact of Eiki Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiki Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiki Kikuchi more than expected).

Fields of papers citing papers by Eiki Kikuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiki Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiki Kikuchi. The network helps show where Eiki Kikuchi may publish in the future.

Co-authorship network of co-authors of Eiki Kikuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Eiki Kikuchi. A scholar is included among the top collaborators of Eiki Kikuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiki Kikuchi. Eiki Kikuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jincheng, et al.. (2025). Noninvasive Electrical Conductivity Mapping by MRI: Its Diagnostic Potential in Distinguishing Thoracic Lesions. NMR in Biomedicine. 39(2). e70218–e70218.
2.
Watanabe, Yasutaka, Makoto Nishio, Kadoaki Ohashi, et al.. (2024). J-TAIL-2: A prospective observational study of atezolizumab (atezo) combination therapy in patients (pts) with non-small cell lung cancer (NSCLC) in Japan.. Journal of Clinical Oncology. 42(16_suppl). 8573–8573.
3.
Miyauchi, Eisaku, Kadoaki Ohashi, Atsushi Osoegawa, et al.. (2024). J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan. JTO Clinical and Research Reports. 6(3). 100783–100783.
4.
Oizumi, Satoshi, Kei Takamura, Toshiyuki Harada, et al.. (2022). Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. International Journal of Clinical Oncology. 27(4). 676–683. 6 indexed citations
5.
Asahina, Hajime, Naoko Yamaguchi, Utano Tomaru, et al.. (2021). A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure. Respiratory Medicine Case Reports. 32. 101364–101364. 3 indexed citations
6.
Sakakibara‐Konishi, Jun, Michiko Sato, Kohei Kasahara, et al.. (2020). Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma. Respiratory Medicine Case Reports. 31. 101170–101170. 3 indexed citations
7.
Kikuchi, Eiki, Junko Kikuchi, Hirofumi Takahashi, et al.. (2020). Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 85(5). 843–853. 12 indexed citations
8.
Kikuchi, Eiki, Junko Kikuchi, Motofumi Suzuki, et al.. (2019). Bromodomain and extraterminal domain inhibition synergizes with WEE1‐inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer. International Journal of Cancer. 146(4). 1114–1124. 27 indexed citations
9.
Sakakibara‐Konishi, Jun, Satoshi Oizumi, Junko Kikuchi, et al.. (2016). Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer. International Journal of Clinical Oncology. 22(2). 257–268. 12 indexed citations
10.
Soucheray, Margaret, Marzia Capelletti, Yanan Kuang, et al.. (2015). Intratumoral Heterogeneity in EGFR -Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition. Cancer Research. 75(20). 4372–4383. 103 indexed citations
11.
Tchaicha, Jeremy H., Esra A. Akbay, Abigail Altabef, et al.. (2014). Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC. Cancer Research. 74(17). 4676–4684. 30 indexed citations
12.
Shimamura, Takeshi, Zhao Chen, Margaret Soucheray, et al.. (2013). Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6183–6192. 158 indexed citations
13.
Mizugaki, Hidenori, Jun Sakakibara‐Konishi, Junko Kikuchi, et al.. (2013). CD133 expression: a potential prognostic marker for non-small cell lung cancers. International Journal of Clinical Oncology. 19(2). 254–259. 48 indexed citations
14.
Xu, Lu, Eiki Kikuchi, Chunxiao Xu, et al.. (2012). Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET. Cancer Research. 72(13). 3302–3311. 88 indexed citations
15.
Yamada, Noriyuki, Satoshi Oizumi, Eiki Kikuchi, et al.. (2010). CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunology Immunotherapy. 59(10). 1543–1549. 133 indexed citations
17.
Shinagawa, Naofumi, Noriyuki Yamada, Hajime Asahina, et al.. (2009). Transbronchial Biopsy for Peripheral Pulmonary Lesions Under Real-time Endobronchial Ultrasonographic Guidance. Journal of Bronchology & Interventional Pulmonology. 16(4). 261–265. 6 indexed citations
18.
Inoue, Tetsuya, Shinichi Shimizu, Rikiya Onimaru, et al.. (2009). Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination. International Journal of Radiation Oncology*Biology*Physics. 75(3). 683–687. 66 indexed citations
19.
Kikuchi, Eiki, Koichi Yamazaki, Toshihiko Torigoe, et al.. (2007). HLA class I antigen expression is associated with a favorable prognosis in early stage non‐small cell lung cancer. Cancer Science. 98(9). 1424–1430. 91 indexed citations
20.
Kikuchi, Eiki, Shigeaki Ogura, Hiroshi Yamamoto, & Akio Takada. (2002). An Autopsy Case of Biphasic Pulmonary Blastoma With Marked Extrapulmonary Growth.. Haigan. 42(4). 277–281.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026